BUZZ-Australia's Genetic Technologies tumbles on discounted placement in US

Reuters04-19

** Shares of Genetic Technologies fall as much as 25.7% to A$0.130, posting their biggest intraday pct decline since Dec. 18, 2023

** Stock hits its lowest level since April 4

** Molecular diagnostics co announces a $2 mln direct offering for its American depository shares $(ADS.AU)$

** Issue price of $2.00 per ADS represents a 39.4% discount to last close

** About 385,600 ASX-listed shares change hands, compared with the 30-day average volume of 59,427

** Stock up 29.6% YTD, as of last close

(Reporting by Aaditya Govind Rao in Bengaluru)

((Aaditya.govindrao@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment